Sirona Medical is a technology company.
Sirona Medical has raised $91.0M across 3 funding rounds.
Key people at Sirona Medical.
Sirona Medical has raised $91.0M in total across 3 funding rounds.
Sirona Medical has raised $91.0M in total across 3 funding rounds.
Sirona Medical's investors include 8VC, GreatPoint Ventures, Jonathan Bush, Kenan Turnacioglu, Canvas Ventures, Foundation Capital, Insight Partners, Khosla Ventures, Mouro Capital, MS&AD Ventures, Jeff Immelt, Summit Partners.
Key people at Sirona Medical.
Sirona Medical is a San Francisco-based healthcare software company that builds RadOS, a cloud-native radiology operating system unifying image management, AI-powered reporting, worklists, and workflows into a single platform.[2][3][4][5] It serves radiologists and healthcare institutions by solving fragmented radiology IT systems—replacing outdated PACS, RIS, and disparate tools with seamless, browser-based access that boosts productivity, reduces administrative burdens, and integrates AI for faster, accurate diagnoses.[3][5][7] Founded in 2018, Sirona has raised over $100M (including a $42M Series C in late 2024), launched RadOS publicly in November 2023, and achieved 100x usage growth in 24 months, becoming the largest single-instance PACS deployment in history.[4][10]
Sirona Medical was founded in 2018 by a team with deep expertise in radiology, healthcare IT, and AI, including CEO Cameron Andrews, drawing from experiences at McKesson, Agfa Healthcare, Box, and Stanford’s Center for Artificial Intelligence in Medicine & Imaging.[2][6] The idea emerged to reimagine radiology for the AI era, addressing pain points like workflow fragmentation and legacy on-premise systems that hindered modern practices.[3][4] Early traction came from design partners—radiology practices and physicians who believed in the vision from inception—leading to RadOS's public launch in November 2023 as the first fully cloud-native radiology stack in over a decade, followed by explosive growth.[4][8]
Sirona stands out through its cloud-native, AI-embedded architecture that eliminates legacy infrastructure baggage:
(Note: Sirona Medical Technologies [1] is a distinct cardiac electrophysiology firm; all details here refer to the radiology software company.)
Sirona rides the cloud-native radiology and AI transformation wave, capitalizing on the shift from rigid, on-premise PACS (unchanged in decades) to elastic, multi-tenant platforms amid rising imaging volumes, radiologist shortages, and AI adoption.[3][8][9] Timing is ideal: post-2023 launch aligns with FHIR standards, multimodal AI maturity, and demand for remote/hybrid workflows, fueled by market forces like burnout reduction and precision diagnostics.[5][6][9] It influences the ecosystem by setting a new paradigm—unifying fragmented tools into "Radiology Untethered," enabling AI as the core engine rather than bolt-ons, and accelerating vendor integrations for broader radiology IT modernization.[3][8][9]
Sirona is poised to dominate cloud radiology with RadOS expansions like enhanced Unify platform features from its $42M Series C, targeting deeper AI orchestration and global scale.[10] Trends like agentic AI, edge computing for imaging, and value-based care will propel it, potentially capturing share from legacy giants as practices prioritize speed and interoperability. Its influence may evolve into an ecosystem orchestrator, powering third-party innovations and redefining radiologist productivity—transforming Sirona from disruptor to indispensable backbone in AI-driven healthcare imaging.[9][10]
Sirona Medical has raised $91.0M across 3 funding rounds. Most recently, it raised $42.0M Series C in November 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2024 | $42.0M Series C | 8VC, GreatPoint Ventures, Jonathan Bush, Kenan Turnacioglu | |
| Nov 1, 2021 | $40.0M Series B | 8VC, GreatPoint Ventures, Jonathan Bush, Kenan Turnacioglu | |
| Aug 1, 2020 | $9.0M Series A | 8VC, Canvas Ventures, Foundation Capital, GreatPoint Ventures, Insight Partners, Khosla Ventures, Mouro Capital, MS&AD Ventures, Jeff Immelt, Summit Partners, Gokul Rajaram, Jonathan Bush, Kenan Turnacioglu |
